Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

TELA Bio (TELA) Enterprise Value (2018 - 2025)

TELA Bio (TELA) has 8 years of Enterprise Value data on record, last reported at -$29.7 million in Q3 2025.

  • For Q3 2025, Enterprise Value fell 71.74% year-over-year to -$29.7 million; the TTM value through Sep 2025 reached -$29.7 million, down 71.74%, while the annual FY2024 figure was -$52.7 million, 12.71% down from the prior year.
  • Enterprise Value reached -$29.7 million in Q3 2025 per TELA's latest filing, up from -$35.0 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$17.3 million in Q3 2024 and bottomed at -$65.8 million in Q1 2021.
  • Average Enterprise Value over 5 years is -$43.3 million, with a median of -$42.8 million recorded in 2025.
  • Peak YoY movement for Enterprise Value: crashed 135.4% in 2023, then skyrocketed 70.27% in 2024.
  • A 5-year view of Enterprise Value shows it stood at -$43.9 million in 2021, then rose by 4.35% to -$42.0 million in 2022, then dropped by 11.21% to -$46.7 million in 2023, then dropped by 12.71% to -$52.7 million in 2024, then skyrocketed by 43.59% to -$29.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Enterprise Value were -$29.7 million in Q3 2025, -$35.0 million in Q2 2025, and -$42.8 million in Q1 2025.